Innate Pharma SA (IPH):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Innate Pharma SA (IPH) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82397FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Innate Pharma SA (Innate Pharma) is a bio-pharmaceutical company. It holds expertise in the areas of immunopharmacology and antibody technology. The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops new monoclonal antibodies that targets receptors and pathways in controlling the activation of innate immunity cells. Innate Pharma’s product portfolio includes Lirilumab, anti-KIR mAb; IPH2201, anti-NKG2A mAb; IPH4102, anti-KIR3DL2 mAb; IPH33, anti-TLR3 mAb; and IPH43, anti-MICA mab. The company has collaborations and partnerships with academic laboratories, clinical centers and industrial leaders. Some of the company’s key partners include Novo Nordisk A/S, Bristol-Myers Squibb, the Institut Gustave Roussy and the Hopital Saint Louis in Paris, and the Institut Paoli-Calmettes in Marseille, among others. Innate Pharma is headquartered in Marseille, France.

Innate Pharma SA Key Recent Developments

Nov 05, 2013: Innate Pharma announces revenue for the first nine months of 2013 and updates on its cash position
Oct 15, 2013: INNATE PHARMA: presents proprietary antibody-drug conjugate technology at the World ADC Summit in San Francisco
Oct 02, 2013: Innate Pharma appoints Nicolai Wagtmann Chief Scientific Officer
Sep 19, 2013: Innate Pharma Announces Financial results for the first half of 2013
Jul 01, 2013: Annual General Meeting of June 28, 2013

This comprehensive SWOT profile of Innate Pharma SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Innate Pharma SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Innate Pharma SA – Key Information
Innate Pharma SA – Overview
Innate Pharma SA – Key Employees
Innate Pharma SA – Key Employee Biographies
Innate Pharma SA – Key Operational Heads
Innate Pharma SA – Major Products and Services
Innate Pharma SA – History
Innate Pharma SA – Company Statement
Innate Pharma SA – Locations And Subsidiaries
Innate Pharma SA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Innate Pharma SA – Business Description
Innate Pharma SA – Corporate Strategy
Innate Pharma SA – SWOT Analysis
SWOT Analysis – Overview
Innate Pharma SA – Strengths
Innate Pharma SA – Weaknesses
Innate Pharma SA – Opportunities
Innate Pharma SA – Threats
Innate Pharma SA – Key Competitors

Section 3 – Company Financial Performance Charts

Innate Pharma SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Innate Pharma SA, Key Information
Innate Pharma SA, Key Ratios
Innate Pharma SA, Share Data
Innate Pharma SA, Major Products and Services
Innate Pharma SA, History
Innate Pharma SA, Key Employees
Innate Pharma SA, Key Employee Biographies
Innate Pharma SA, Key Operational Heads
Innate Pharma SA, Other Locations
Innate Pharma SA, Subsidiaries
Innate Pharma SA, Key Manufacturing facilities
Innate Pharma SA, Key Competitors
Innate Pharma SA, SWOT Analysis
Innate Pharma SA, Ratios based on current share price
Innate Pharma SA, Annual Ratios
Innate Pharma SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Innate Pharma SA, Performance Chart
Innate Pharma SA, Ratio Charts

★海外企業調査レポート[Innate Pharma SA (IPH):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BBX Capital Corporation:戦略・SWOT・企業財務分析
    BBX Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary BBX Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Noel Gifts International Ltd. (543):企業概要、財務及び戦略的SWOT分析
    Summary Noel Gifts International Ltd (Noel Gifts) is a specialist gift company. The company's products include flowers, hampers and gift items. It also concentrates on investment and development of properties. Noel Gifts operates a franchise program that provides franchisees the right to use the com …
  • Hedcor, Inc.:企業のM&A・提携動向(発電分野)
    Summary Hedcor, Inc. (Hedcor), a subsidiary of Aboitiz Power Corporation, formerly Benguet Hydro power Corp renewable energy company that develops, installs and maintains mini hydro power plants. The company generates renewable energy from run-of-river hydropower systems. Hedcor develops a Manolo Fo …
  • MannKind Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' MannKind Corporation Mergers an …
  • Matra Petroleum plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Matra Petroleum plc Mergers and …
  • Eco (Atlantic) Oil & Gas Ltd (EOG):企業のM&A・提携動向(石油・ガス分野)
    Summary Eco (Atlantic) Oil & Gas Ltd. (Eco) is a mineral exploration company that concentrates on the identification, acquisition and development of oil and gas exploration projects in Africa. The company offers products such as oil and gas. Its project includes Namibia offshore; cooper license 2012 …
  • Ikanos Communications, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ikanos Communications, Inc. Mer …
  • SNGN Romgaz S.A. (SNG):企業のM&A・提携動向(石油・ガス分野)
    Summary SNGN Romgaz S.A. (Romgaz), formerly Societatea Nationala de Gaze Naturale Romgaz SA is an oil and gas company that explores, produces, and supplies natural gas and electricity. The company provides operation of Iernut thermoelectric power station, and offers electric power supply. Its explor …
  • Oklahoma Medical Research Foundation(製薬・医療分野):企業M&A動向
    Summary Oklahoma Medical Research Foundation (OMRF) is a biomedical research organization. The center develops treatments for human diseases such as heart disease, cancer, lupus and Alzheimer’s disease. Its conducts several programs ,such as Arthritis and Clinical Immunology Research Program, Cardio …
  • Acorn Energy, Inc. (ACFN)-石油・ガス分野:企業M&A・提携分析
    Summary Acorn Energy, Inc. (Acorn) is an energy technology holding company which operates electricity delivery, emergency back-up power generation, and remote monitoring and control systems through its subsidiaries. The company develops and produces sonar systems for the defense, HLS, energy and com …
  • Neogen Corporation:企業のM&A・提携・投資分析
    Neogen Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Neogen Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • J. M. Huber Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' J. M. Huber Corporation Mergers …
  • Thai Reinsurance Public Co., Ltd.:企業の戦略・SWOT・財務分析
    SummaryThai Reinsurance Public Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the co …
  • Aben Resources Ltd (ABN):企業の財務及び戦略的SWOT分析
    Summary Aben Resources Ltd. (Aben) is a mineral exploration company that explores and develops gold, silver, uranium and tungsten. The company offers products such as uranium, lithium, gold, silver, lead, zinc and copper. It undertakes projects such as yukon, selwyn recce NWT, mann lake project at e …
  • Morphic Technologies AB:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Morphic Technologies AB Mergers …
  • Syndax Pharmaceuticals Inc (SNDX)-医療機器分野:企業M&A・提携分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is aclinical stage biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate, entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for t …
  • Nikkiso Co., Ltd. (6376):企業のM&A・提携動向(医療機器分野)
    Summary Nikkiso Co., Ltd. (Nikkiso) is a diversified company, which develops, manufactures and markets medical equipment and industrial instruments. Nikkiso classifies its products into five categories: pumps, sampling systems and chemical feed systems; particle size characterization; equipment for …
  • Metro Inc.:企業の戦略・SWOT・財務分析
    Metro Inc. - Strategy, SWOT and Corporate Finance Report Summary Metro Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Fraser and Neave, Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Fraser and Neave, Limited Merge …
  • National Oilwell Varco, Inc. (NOV):企業の財務及び戦略的SWOT分析
    National Oilwell Varco, Inc. (NOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆